The laboratory test results for patient Stefan Gabriel Tabirca show that his COVID-19 PCR test was positive. The test was performed on a nasopharyngeal exudate sample taken on October 19, 2021 at 2:46pm. The test used RT-qPCR technology from the Sacace Detection Kit to detect two specific SARS-CoV-2 genes, and had a detection limit of 0.5 copies/ul. The attending physician will interpret the positive result in the patient's clinical context.
The laboratory test results for patient Stefan Gabriel Tabirca show that his COVID-19 PCR test was positive. The test was performed on a nasopharyngeal exudate sample taken on October 19, 2021 at 2:46pm. The test used RT-qPCR technology from the Sacace Detection Kit to detect two specific SARS-CoV-2 genes, and had a detection limit of 0.5 copies/ul. The attending physician will interpret the positive result in the patient's clinical context.
The laboratory test results for patient Stefan Gabriel Tabirca show that his COVID-19 PCR test was positive. The test was performed on a nasopharyngeal exudate sample taken on October 19, 2021 at 2:46pm. The test used RT-qPCR technology from the Sacace Detection Kit to detect two specific SARS-CoV-2 genes, and had a detection limit of 0.5 copies/ul. The attending physician will interpret the positive result in the patient's clinical context.
The result refers to the tested sample. The interpretation of the result is made strictly in accordance with "Methodology for surveillance of acute respiratory syndrome with the new coronavirus (COVID-19)" issued by the National Institute of Public Health of Romania . Technology used RT-qPCR.Reagents used: Sacace Detection Kit IVD. The detection limit is 0.5 copies / ul by detecting two specific Sars-Co2 genes Nasopharyngeal exudate
The result will be interpreted by the attending physician in a clinical context.
The results of the analysis bulletin refer only to the samples subjected to analysis. CLINICA does not assume responsibility for the correctness of the information declared by the patient. Full reproduction is prohibited. or part of the analysis bulletin for purposes other than the one for which it was issued. Respecting the confidentiality of its patients, BINISAN does not require official personal identification documents.